Aquestive Therapeutics
Price & Volume
Stats
See more52W Range | $2.12-$6.43 |
Market Cap | $724.6M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $44.1M |
Revenue Growth (YoY) | -50.2% |
Gross Profit (12 Mos) | $26.9M |
Diluted EPS | -$0.69 |
News
See moreYahoo Finance • 3 days ago
Mixed Catalysts Drive After-Hours Moves In MRM, LEXX, SHOT, AQST, And OVID
Yahoo Finance • 25 days ago
Aquestive jumps as FDA says no AdCom for allergy therapy Anaphylm
Yahoo Finance • 25 days ago
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
Yahoo Finance • 2 months ago
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
About
CEO | Mr. Daniel Barber |
Address | 30 Technology Drive, Warren, NJ, United States, 07059 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 142 |
